Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Safoura Khajeniazi"'
Autor:
Ameer Abdulraheem Handhal, Mahin Gholipur, Fatima Mohammad zadeh, Somayeh Ghorbani, Safoura Khajeniazi
Publikováno v:
Journal of Clinical and Basic Research, Vol 8, Iss 2, Pp 1-4 (2024)
Background: Hypothyroidism is a significant contributor to complications in various metabolic and cardiovascular diseases. Thyroid hormones, including lipids, play a crucial role in macromolecule metabolism. C-reactive protein (CRP) is a key marker f
Externí odkaz:
https://doaj.org/article/71cbc626621a40cea0617bbe8a42f029
Autor:
Mundher Mohammad Hamzeh Aldulaimi, Afsaneh Shafiei, Somayeh Ghorbani, Fatima Mohammadzadeh, Safoura Khajeniazi
Publikováno v:
Endocrinology, Diabetes & Metabolism, Vol 7, Iss 6, Pp n/a-n/a (2024)
ABSTRACT Background The association of serum FABP4 and other biochemical‐related parameters is important to determine complications of hypothyroidism. This study aimed to evaluate serum FABP‐4 levels in hypothyroidism patients in comparison with
Externí odkaz:
https://doaj.org/article/7b85f03dad7a43bbb94e684245aa4625
Publikováno v:
Journal of Materials Research and Technology, Vol 19, Iss , Pp 3966-3979 (2022)
Extensive wounds might result in massive infections, deformation, or organ malfunction. Conventional therapies like skin grafting possess some drawbacks, therefore, the urge of developing tissue engineering techniques and skin substitutes has emerged
Externí odkaz:
https://doaj.org/article/f7de488f2ee84f72955f83252792fec4
Autor:
Saeideh Edalati, Safoura Khajeniazi
Publikováno v:
Regenerative Therapy, Vol 20, Iss , Pp 26-31 (2022)
Introduction: One of the diseases in developed counties is myocardial infarction that causes the death of many people. A Problem of many new drugs usage concerns their assessment for applying therapeutically for heart disease. Previous studies used a
Externí odkaz:
https://doaj.org/article/4270abbacd8c4a0ab17201eaaf0e2f0d
Publikováno v:
مجله دانشگاه علوم پزشکی گرگان, Vol 21, Iss 3, Pp 41-48 (2019)
Background and Objective: Cardiovascular diseases and heart failure are major diseases in developed countries. Stem cells showed specific features to play an important role in heart disease treatment. One of the most common compounds has been used to
Externí odkaz:
https://doaj.org/article/27e73b243aa94928bca2e10d3d117215
Autor:
Saeideh Edalati, Safoura Khajeniazi
Publikováno v:
Cardiovascular Engineering and Technology. 12:505-514
Cardiovascular diseases (CVDs) are major causes of mortality in developing countries. One of the challenges during CVDs studies is the creation of a damaged model of the heart. Many injured models of cardiac diseases are created by using chemical and
Autor:
Maryam Sadegh Shesh Poli, Abdolvahab Moradi, Safoura Khajeniazi, Mohammad Reza Kalani, Abdoljalal Marjani, Nasser Behnampour
Publikováno v:
Cancer Management and Research. 12:973-980
Background and Aims MicroRNAs including miR146a have a regulatory role on the expression of genes and act with binding to 3'-UTR region of the genes. Cyclooxygenase-2 (COX-2) is involved in carcinogenesis as an inflammatory marker, and microRNA-146a
Class III histone deacetylases (sirtuins) have essential roles in many cellular processes. They are related to prolonged longevity and to the cancer pathogenesis and neuronal illnesses. Sirtuin 2 inhibition as a vital enzyme which are involved in ove
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10cea5cc521a2a15fcd286cbb6317001
https://doi.org/10.21203/rs.3.rs-1485544/v1
https://doi.org/10.21203/rs.3.rs-1485544/v1
Publikováno v:
Clinica Chimica Acta. 474:34-37
Type 2 diabetes mellitus (T2DM) is one of the diseases which depend on the obesity associated with insulin resistance. Various factors, such as a reduction in the activity of paraoxonase-1 enzyme (PON1), could affect T2DM. PON1 is a multifunctional e
Autor:
Mahdieh Pourafshar, Safoura Khajeniazi, Arsham Banisadr, Yaghoub Yazdani, Yaghoub Safdari, Kamal Veisi
Publikováno v:
International Journal of Peptide Research and Therapeutics. 24:171-178
Recombinant expression and EGFR-binding activity assay of single chain nimotuzumab (nimotuzumab scFv) is reported in this study. The scFv was produced in VH-linker-VL format in Origami™ 2(DE3)pLysS bacterial cells and purified using Ni-TNA resin co